🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
About 46% of patients suffering from Parkinson's disease present pain disor...
Status
Completed
Location
University Hospital Toulouse
Start Date
2009-03
Trial ID
NCT00940914
Treatments Being Tested
Post-dural puncture headache (PDPH) is the most prevalent complication in p...
Status
Completed
Location
IRCCS Neuromed
Start Date
2022-01-11
Trial ID
NCT06640634
Treatments Being Tested
Airway microbiota pattern may related the preschool asthma exacerbation. Th...
Status
Completed
Location
Children's Hospital of Fudan University
Start Date
2021-10-18
Trial ID
NCT04527016
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of com...
Status
Completed
Location
Altana Pharma/Nycomed
Start Date
2005-01
Trial ID
NCT00163488
Treatments Being Tested
BBR 2778 is a novel aza-anthracenedione that has activity in experimental t...
Status
Withdrawn
Location
Northwest Alabama Cancer Center
Start Date
2007-09
Trial ID
NCT00577161
Treatments Being Tested
This study is designed to provide data about the 24 hours FEV1 profile, saf...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-11
Trial ID
NCT00557440
The aim of this study is to investigate the effects of spironolactone on li...
Status
Completed
Location
Shanghai Tongji Hospital, Tongji University
Start Date
2018-01-01
Trial ID
NCT02907749
Treatments Being Tested
Relatively little information is available about the effects of salmeterol/...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-11
Trial ID
NCT00549146
Recent stent design improvements focus on decreasing stent fracture rates w...
Status
Withdrawn
Location
Cardiovascular center, Korea University Guro Hospital
Start Date
2013-01
Trial ID
NCT01570803
Treatments Being Tested
This is a randomized, placebo-controlled, 2-period crossover, escalating re...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-02-09
Trial ID
NCT02991859